Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Audiological Disturbances in Vitiligo

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2007 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00484224
First received: June 7, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted

June 7, 2007
June 7, 2007
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Audiological Disturbances in Vitiligo
Not Provided
The purpose of this study is to determine wether vitiligo patients have more audiological abmnormalities, than the healthy population.
Not Provided
Observational
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
  • Vitiligo
  • Hearing Loss
Not Provided
Not Provided
Aydogan K, Turan OF, Onart S, Karadogan SK, Tunali S. Audiological abnormalities in patients with vitiligo. Clin Exp Dermatol. 2006 Jan;31(1):110-3.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • vitligo patients under 50. healthy patients under 50 for control group

Exclusion Criteria:

  • above age 50. systemic disease. exposure to loud noise in past. familial history of deafness use of autotoxuc drugs or steroids. autoimmune/metabolic/neurologic/vascular disease
Both
3 Years to 50 Years   (Child, Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT00484224
qwer1234-HMO-CTIL
Not Provided
Not Provided
Not Provided
Not Provided
Hadassah Medical Organization
Not Provided
Principal Investigator: Arieh Ingber, Prof. Hadassah Medical Organization
Hadassah Medical Organization
May 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP